https://stock.noler.com/us/stock/resolute-oncology-inc https://stock.noler.com/us/stock/resolute-oncology-inc/accounts-payable https://stock.noler.com/us/stock/resolute-oncology-inc/accounts-payable-related-parties-current https://stock.noler.com/us/stock/resolute-oncology-inc/accounts-payable-trade-current https://stock.noler.com/us/stock/resolute-oncology-inc/accounts-receivable https://stock.noler.com/us/stock/resolute-oncology-inc/accumulated-depreciation https://stock.noler.com/us/stock/resolute-oncology-inc/accumulated-oci-foreign-currency-translation-adjustment-net-of-tax https://stock.noler.com/us/stock/resolute-oncology-inc/acquisition-consideration-transferred-equity-interests-issued-and-issuable https://stock.noler.com/us/stock/resolute-oncology-inc/additional-paid-in-capital https://stock.noler.com/us/stock/resolute-oncology-inc/capital-leases-lessee-balance-sheet-assets-by-major-class-other-property-plant-and-equipment-net https://stock.noler.com/us/stock/resolute-oncology-inc/cash-and-equivalents https://stock.noler.com/us/stock/resolute-oncology-inc/cash-flow-breakdown https://stock.noler.com/us/stock/resolute-oncology-inc/common-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/resolute-oncology-inc/common-stock-value https://stock.noler.com/us/stock/resolute-oncology-inc/comprehensive-income https://stock.noler.com/us/stock/resolute-oncology-inc/contract-administration-expense https://stock.noler.com/us/stock/resolute-oncology-inc/convertible-notes-payable-current https://stock.noler.com/us/stock/resolute-oncology-inc/cost-of-revenue https://stock.noler.com/us/stock/resolute-oncology-inc/cover-page-shares-outstanding https://stock.noler.com/us/stock/resolute-oncology-inc/current-assets https://stock.noler.com/us/stock/resolute-oncology-inc/current-liabilities https://stock.noler.com/us/stock/resolute-oncology-inc/deferred-tax-assets-operating-loss-carryforwards https://stock.noler.com/us/stock/resolute-oncology-inc/deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/resolute-oncology-inc/deposit-liabilities-accrued-interest https://stock.noler.com/us/stock/resolute-oncology-inc/depreciation https://stock.noler.com/us/stock/resolute-oncology-inc/depreciation-and-amortization https://stock.noler.com/us/stock/resolute-oncology-inc/development-stage-enterprise-deficit-accumulated-during-development-stage https://stock.noler.com/us/stock/resolute-oncology-inc/due-from-related-parties https://stock.noler.com/us/stock/resolute-oncology-inc/earnings-per-share-basic-and-diluted https://stock.noler.com/us/stock/resolute-oncology-inc/employee-related-liabilities-current https://stock.noler.com/us/stock/resolute-oncology-inc/exchange-rate-effect-on-cash https://stock.noler.com/us/stock/resolute-oncology-inc/exploration-costs https://stock.noler.com/us/stock/resolute-oncology-inc/financing-cash-flow https://stock.noler.com/us/stock/resolute-oncology-inc/form-d-stocks https://stock.noler.com/us/stock/resolute-oncology-inc/goodwill https://stock.noler.com/us/stock/resolute-oncology-inc/goodwill-acquired https://stock.noler.com/us/stock/resolute-oncology-inc/gross-profit https://stock.noler.com/us/stock/resolute-oncology-inc/impairment-of-ongoing-project https://stock.noler.com/us/stock/resolute-oncology-inc/income-loss-from https://stock.noler.com/us/stock/resolute-oncology-inc/income-tax https://stock.noler.com/us/stock/resolute-oncology-inc/income-taxes-paid https://stock.noler.com/us/stock/resolute-oncology-inc/increase-decrease-in-accounts-payable https://stock.noler.com/us/stock/resolute-oncology-inc/increase-decrease-in-accounts-payable-trade https://stock.noler.com/us/stock/resolute-oncology-inc/increase-decrease-in-accrued-salaries https://stock.noler.com/us/stock/resolute-oncology-inc/increase-decrease-in-interest-payable-net https://stock.noler.com/us/stock/resolute-oncology-inc/increase-decrease-in-inventories https://stock.noler.com/us/stock/resolute-oncology-inc/increase-decrease-in-other-accrued-liabilities https://stock.noler.com/us/stock/resolute-oncology-inc/increase-decrease-in-prepaid-expense https://stock.noler.com/us/stock/resolute-oncology-inc/interest-and-other-income https://stock.noler.com/us/stock/resolute-oncology-inc/interest-expense https://stock.noler.com/us/stock/resolute-oncology-inc/interest-paid https://stock.noler.com/us/stock/resolute-oncology-inc/interest-payable-current https://stock.noler.com/us/stock/resolute-oncology-inc/inventory https://stock.noler.com/us/stock/resolute-oncology-inc/investing-cash-flow https://stock.noler.com/us/stock/resolute-oncology-inc/investment-income-interest https://stock.noler.com/us/stock/resolute-oncology-inc/net-change-in-cash https://stock.noler.com/us/stock/resolute-oncology-inc/net-income https://stock.noler.com/us/stock/resolute-oncology-inc/notes-payable https://stock.noler.com/us/stock/resolute-oncology-inc/oci-foreign-currency-transaction-and-translation-gain-loss-arising-net-of-tax https://stock.noler.com/us/stock/resolute-oncology-inc/operating-cash-flow https://stock.noler.com/us/stock/resolute-oncology-inc/operating-expenses https://stock.noler.com/us/stock/resolute-oncology-inc/operating-income https://stock.noler.com/us/stock/resolute-oncology-inc/operating-leases-rent-expense-net https://stock.noler.com/us/stock/resolute-oncology-inc/other-assets https://stock.noler.com/us/stock/resolute-oncology-inc/other-income https://stock.noler.com/us/stock/resolute-oncology-inc/other-notes-payable-current https://stock.noler.com/us/stock/resolute-oncology-inc/prepaid-expense-and-other-assets https://stock.noler.com/us/stock/resolute-oncology-inc/proceeds-from-notes-payable https://stock.noler.com/us/stock/resolute-oncology-inc/proceeds-from-stock-issued https://stock.noler.com/us/stock/resolute-oncology-inc/property-plant-and-equipment-gross https://stock.noler.com/us/stock/resolute-oncology-inc/public-float https://stock.noler.com/us/stock/resolute-oncology-inc/repayments-of-related-party-debt https://stock.noler.com/us/stock/resolute-oncology-inc/retained-earnings https://stock.noler.com/us/stock/resolute-oncology-inc/revenue https://stock.noler.com/us/stock/resolute-oncology-inc/salaries-and-wages https://stock.noler.com/us/stock/resolute-oncology-inc/shareholders-equity https://stock.noler.com/us/stock/resolute-oncology-inc/shares-authorized https://stock.noler.com/us/stock/resolute-oncology-inc/shares-issued https://stock.noler.com/us/stock/resolute-oncology-inc/tax-reconciliation-change-in-deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/resolute-oncology-inc/total-assets https://stock.noler.com/us/stock/resolute-oncology-inc/total-liabilities https://stock.noler.com/us/stock/resolute-oncology-inc/total-liabilities-and-equity https://stock.noler.com/us/stock/resolute-oncology-inc/weighted-average-number-of-share-outstanding-basic-and-diluted